BrainXell, Inc. today announced that data will be presented during poster sessions at the 2025 Society for Neuroscience (SfN) ...

Arima Genomics announced that it will present new data at the Association for Molecular Pathology (AMP) 2025 Annual Meeting.

Niktimvo (axatilimab-csfr) is a first-in-class colony stimulating factor-1 receptor (CSF-1R)-blocking antibody approved for use in the U.S. for the treatment of chronic graft-versus-host disease (GVHD ...

A senior attending high school in Runnels County went to Japan at the beginning of November to present a research paper she ...

Novel combination with neoadjuvant eftilagimod alfa (efti) achieves significant 51.5% tumour hyalinization/fibrosis across ...

A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...

VENTURE Study Exploratory Analysis Shows VK2735 Improved Cardiometabolic Parameters After 13 Weeks; Reducing Prediabetes and Metabolic Syndrome SAN DIEGO, Nov. 6, 2025 /PRNewswire/ -- Viking ...

Abstract available on ASH websiteSAN DIEGO and TORONTO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” ...

University faculty provides insight on AI research programs, including the RISE initiative and iTREDS program, while also ...

"We continue to add to our body of clinical evidence. At SABCS 2025, we look forward to four poster presentations ...

Incyte will present an expansive slate of research at the 2025 American Society of Hematology (ASH) Annual Meeting, highlighting new data across its myeloproliferative neoplasm (MPN), ...